Following on from our successful 
National Institute for Health Research (NIHR) Diagnostic Evidence Co-operative Newcastle (DEC), which ran from 2013-2017, and a
fter a competitive national process, Newcastle has been chosen to host one of the NIHR MedTech and In Vitro Diagnostics Co-operatives (MIC) effective from January 2018.  
Our new website is currently under development. We will continue to update this one until it's ready! Please check back again soon!

The Newcastle In Vitro Diagnostics Co-operative (Newcastle MIC) is one of 11 MICs set up to provide a centre for excellence for the development and evaluation of new effective diagnostic tests.  We will work closely with the diagnostics industry and build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially supplied in vitro diagnostic (IVD) tests so they will be introduced more rapidly and effectively for patient benefit.

The Newcastle MIC is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.  We will build collaborations with: the diagnostic industry; clinicians and other healthcare professionals; patient groups; commissioners; academic researchers including heath economists and other NIHR MICs.  

The Newcastle MIC facilitates the generation of high quality evidence on clinical validity, utility and cost-effectiveness of in vitro diagnostic medical devices (IVDs) for use in the NHS.
For more information see About us

Newly funded NIHR Medtech and In vitro diagnostic Co-operatives announced

To coincide with the publication of the Life Science Industrial Strategy, Health Secretary Jeremy Hunt, announces £14.25 million funding to support 11 NIHR Medtech and In vitro diagnostic Co-operatives (MICs). 

News & Developments

Newcastle MIC Mixed Methods Methodologist Vacancy 

Interested in joining a growing team of diagnostic test evaluators within our In vitro Diagnostics Co-operative? Check out our exciting new role for a mixed methods researcher in our team!  Deadline is 20th May 2018.  Click here for more details!

NIHR DEC Newcastle play key role in development of NICE Guideline

Familial hypercholesterolaemia: identification and management

Evidence reviews for case-finding, diagnosis and statin monotherapy

17/145 - NIHR Efficacy and Mechanism Evaluation (EME) Programme researcher-led will fund ambitious studies evaluating interventions that have the potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. The deadline for applications is 1pm, 27 March 2018

17/136 - NIHR Health Technology Assessment (HTA) Programme - Sepsis. Invites proposals for the evaluation of interventions to improve the identification, diagnosis and management of sepsis. Deadline for  stage 1 applications is 1pm, 28 March 2018 

Biomedical Catalyst 2017 round 4: primer and late stage awards support the development of innovative healthcare products, technologies and processes. Closes Wednesday 7 February 2018 12:00pm. 

Are you set for the Medical Devices Regulations?

Read here for more information and see the following BSI report

£££ See here for recent funding opportunities £££ 

The DEC is funded by the NIHR